Zydus Wellness Q1 results show revenue fell from 713.7 crores to 704.5 crores, a -1.29% decrease in growth. EPS down from ₹22.84 to ₹17.35, down by -24.04%.
First, Let’s Begin with Quarter-on-Quarter Basis:
Zydus Wellness shared its Q1 results on Thursday. They earned 704.5 crores in revenue this quarter, but that’s less than the 713.7 crores they made last quarter. Unfortunately, the company’s growth decreased by -1.29 percent when comparing the two quarters.
In terms of profits, the company’s PAT (Profit After Tax) for this quarter was 110.4 crores, down from 145.3 crores in the previous quarter. Their quarter-to-quarter growth decreased by -24.02 percent.
The company’s EPS (Earnings Per Share) this quarter is ₹17.35, which is a decrease of -24.04% from the ₹22.84 EPS in the previous quarter.
Now, Let’s Analyze the Results on a Year-over-Year Basis:
The company made a total revenue of 704.5 crores this year (2023), which is 0.87 percent higher than last year’s total revenue of 698.4 crores.
This year’s PAT (Profit After Tax) is 110.4 crores, which is also -19.42% lower than last year’s PAT of 137 crores.
The EPS (Earnings Per Share) for this year is ₹17.35, which is -19.41% less than the EPS of ₹21.53 earned last year.
Zydus Wellness Share Dividend Announcement / Record Date:
The record date for the dividend has not arrived yet.
About Zydus Wellness:
Zydus Wellness, based in Ahmedabad, India, is a consumer goods company that specializes in manufacturing nutrition and skincare products. It operates as a subsidiary of Zydus Lifesciences, a pharmaceutical company. The company’s product portfolio includes popular brands such as Glucon-D, Sugar Free, EverYuth, Complan, and Nycil.
Download the Full PDF of Zydus Wellness Q1 Results: Click Here
For more of the Latest News, Click Here